1.Circannual rhythms of parathyroid hormone-related protein in growing rats after functional mandibular protrusion
Jiangning LI ; Yangxi CHEN ; Zhengrong WANG
Journal of Practical Stomatology 2001;0(01):-
Objective:To investigate the levels of parathyroid hormo ne -related protein(PTHrP) in mandibular condylar cartilage during mandible forwar d positioning in different seasons. Methods:64 SD rats were rand omly divided into four groups according to seasons. Orthodontic appliance was us ed in 32 rats for 12 hours each day in daytime for mandibular protrusion. 8 rats were sacrificed at each season time point.Condyle samples were processed for PT HrP detection by a two-site immunoradiometric assay (IRMA) method.Another 32 ra ts without treatment were used as the controls.Macroscopic and microscopic appro ach were applied to analyze the results. Results:The level of P THrP in mandibular condylar cartilage(MCC) in the group of orthodontic treatmen t was higher than that in the control group(P
2. A feasibility study of fractional flow reserve assessment for carotid artery stenosis interventional therapy
Chinese Journal of Cerebrovascular Diseases 2019;16(8):411-415
Objective This study aimed to evaluate the feasibility and safety of interventional therapy for carotid atherosclerotic stenosis using fractional flow reserve (FFR). Methods All 30 consecutive patients with symptomatic severe carotid artery stenosis (lumen stenosis > 70%) and stent implantation were retrospectively recruited. Among them, 25 patients were with cerebral infarction and 5 patients with transient ischemic attack. The blood flow of carotid atherosclerotic stenosis was measured by pressure wire. The stenosis rate,FFR (distal/proximal pressure ratio) and translesional pressure gradient (proximal pressure-distal pressure) were measured before and after intervention. Correlation between stenosis rate and FFR or translesional pressure gradient was analyzed by the Pearson correlation test. Results All 30 patients had pressure wire successfully pass the stenosis, and FFR and translesional pressure gradients were measured. Before intervention, the mean stenosis rate, FFR and translesional pressure gradients were (84 ± 6) %,0. 67 ±0. 15 and (32 ± 7) mmHg. Corresponding post-intervention measurements were (30 ± 10)%,0. 82 ± 0. 11 and (18 ± 9) mmHg respectively. The post-intervention vascular stenosis rate and translesional pressure gradient were significantly lower than those before intervention with statistically significant differences (all P <0. 01). Before intervention,vascular stenosis rate was significantly correlated with FFR and translesional pressure gradient (r was - 0 . 8 6 and 0.96, respectively, all P < 0. 01). No intracerebral hemorrhage and vascular dissection occurred by vascular puncture rupture in patients during FFR and translesional pressure gradient measurement by pressure wire. Conclusion Application of FFR is feasible and safe to evaluate the interventional treatment of carotid atherosclerosis stenosis,but more studies are needed for further verification.
3.Chitosan inhibits high glucose-induced peroxidation and monocytes adhesion to vascular endothelial cells
Chunming WANG ; Lei DONG ; Huajia DIAO ; Jiangning CHEN ; Junfeng ZHANG
Chinese Pharmacological Bulletin 2003;0(09):-
Aim To study the inhibitory effect of chitosan on peroxidation and monocytes adhesion to vascular endothelial cells induced by high concentration of glucose. Methods Human umbilical vascular endothelial cells (HUVEC) were treated with high glucose, and high glucose with different concentrations of chitosan for 24 h. Hydroxyl radicals (OH?) and malon-dialdehyde (MDA) were measured. Monocytes Raw 264.7 were pre-incubated with Rhodamin123, and then co-cultured with HUVEC for 30 min, followed bymicroscope observation and determination of the monocytes adhesion. Finally, the mRNA expression of vascular cell adhesion molecular-1 (VCAM-1) was evaluated by reverse transcription polymerase chain reaction (RT-PCR). Results Concentrations of OH? and MDA in HUVEC increased after incubation with high glucose. Both of the amount of adhesive monocytes and mRNA expression level of VCAM-1 in HUVEC were induced by high glucose. Inversely, chitosan inhibited these changes in a dose-dependent manner without any cytotoxicity to cells. Conclusion Chitosan can scavenge free radicals and prevent peroxidative injury on vascular endothelial cells, which further down-regulates the expression of VCAM-1 and consequently inhibits the adhesion of monocytes to endothlial cells.
4.Effect of antidepressant intervention on mood state of at or around the time of radiation therapy
Jianhua CHEN ; Guilan LI ; Dashan WANG ; Jiangning DONG ; Ming PAN ; Xinmin LIU
Chinese Journal of Behavioral Medicine and Brain Science 2010;19(12):1074-1075
Objective To explore the effect of antidepressant intervention on mood state of at or around the time of radiation therapy. Methods 62 hospitalized patients with cancer receiving radiotherapy were divided into two groups by the order of the time when they accept the radiotherapy which called intervention group ( antidepressant fluoxetine group) and control group. And the two groups patients filled out Hamilton Anxiety Scale( HAMA )and Hamilton Depression Scale (HAMD) at or around the time of radiation therapy to investigate the effects of fluoxetine on anxiety and depression. Results The scores of HAMA and HAMD showed that there was no differences between the intervention group and the control group before the radiotherapy. There was significant difference during the radiotherapy ( 6.41 ± 2.30 ) vs ( 9.29 ± 5.62 ); ( 8.80 ± 3. 048 ) vs ( 12.22 ± 8.32 ) and two weeks after the end of the radiotherapy ( 4.90 ± 1.71 ) vs ( 12.32 ± 7.24 ); ( 6.83 ± 2.47 ) vs ( 16.09 ± 8.61 ) between antidepressant fluoxetine group and control group(P < 0.05 ). Conclusion More attention should be paid to mental health and antidepressant can alleviate anxiety and depression of the cancer patients'at or around the time of radiotherapy.
5.Diagnostic performance of ADC value and texture features based on T 2WI fat suppressed image to distinguish benign and malignant soft tissue tumors
Dong CHEN ; Bin SHI ; Mingxue ZHENG ; Fei GAO ; Jiangning DONG ; Demei SONG ; Na ZHAO ; Feng CAO ; Xinyang WEI
Chinese Journal of Radiology 2021;55(3):282-287
Objective:To investigate the value of ADC derived from DWI combined with texture analysis derived from T 2WI fat suppressed images in distinguishing benign and malignant soft tissue tumors. Methods:The MRI and DWI images of 94 patients with soft tissue tumors (44 cases with malignant and 50 cases with benign) confirmed by pathology were analyzed retrospectively in the First Affiliated Hospital of USTC West District. ADC values of solid components were measured at GE ADW4.6 workstation. The texture features were extracted by manually drawing the ROI on the maximum level of the T 2WI fat suppressed images; the ADC values and texture parameters between the two groups were statistically analyzed by SPSS17.0, and the multivariate logistic regression model were conducted to analyze and calculate the diagnostic performance. Results:ADC value of benign and malignant soft tissue tumors was (1.6±0.3)×10 -3 mm 2/s, (1.2±0.5)×10 -3 mm 2/s, respectively, and the difference was statistically significant( t=-5.382, P<0.05). Taking 1.28×10 -3 mm 2/s as the critical value, the area under curve (AUC) for the diagnosis of benign and malignant soft tissue tumors was 0.783, the sensitivity was 92.00%, and the specificity was 65.91%. Among the texture features, the AUC of frequency size, skewness, Inertia All Direction_offset7, Inverse Difference Moment angle0_offset1, Inverse Difference Moment angle0_offset7 and Haralick Correlation All Direction_offset4_SD distinguishing benign and malignant soft tissue tumors were 0.825, 0.739, 0.826, 0.816, 0.820 and 0.783, respectively. The AUC, sensitivity and specificity of the best predictive model distinguishing benign and malignant soft tissue tumors were 0.930, 88.00% and 86.36% respectively using multivariate logistic regression analysis. Conclusion:ADC combined with texture analysis is of great value in preoperative differentiation of benign and malignant soft tissue tumors.
6.Plasma SCF/c-kit Levels in Patients with Dipper and Non-Dipper Hypertension.
Hai-Lan ZHONG ; Chong-Li XU ; Guang-Sheng CHEN ; Xiu-Mei CHEN
Chinese Medical Sciences Journal 2017;32(4):232-238
Objective The aim of this study was to investigate the relationship between peripheral plasma stem cell factor (SCF)/c-kit levels and the types of dipper and non-dipper hypertension in hypertensive patients. Methods This cross-sectional study included newly diagnosed hypertensive patients who underwent 24-hour ambulatory blood pressure monitor (ABPM) between January 2009 and 2012 in Jiangning city. Patients were divided into the dipper group and the non-dipper group according to ABPM measurements. The levels of SCF and its receptor c-kit, tumor necrosis factor-α (TNF-α) and interleukin 6 (IL-6) in peripheral blood were measured via enzyme-linked immunosorbent assays. The serum levels of glucose and lipid were examined as well. The levels of SCF/c-kit were compared between the dippers and the non-dippers; and their correlation with 24-hour mean systolic blood pressure (MSBP), 24-hour mean diastolic blood pressure (MDBP), TNF-α and IL-6 were investigated using linear regression analyses statistically. Results A total of 247 patients with newly diagnosed hypertension were recruited into the study, including 116 non-dippers and 131 dippers. The levels of peripheral plasma SCF were higher in non-dipper group (907.1±52.7 ng/L vs. 778.7±44.6 ng/L; t=2.837, P<0.01), and the levels of c-kit were higher in non-dipper group too (13.2±1.7 μg/L vs 9.57±1.4 μg/L; t=2.831, P<0.01). Linear regression analysis revealed that SCF/c-kit levels were significantly positively correlated with MSBP, MDBP, plasma TNF-α, and IL-6 levels (all P<0.01). Conclusions Peripheral plasma SCF/c-kit levels are higher in patients with non-dipper hypertension than those with dipper one, and significantly correlate with 24-hour MSBP, 24-hour MDBP, serum TNF-α and IL-6 levels.
7.Fluid overload-associated large B-cell lymphoma: report of a case.
W CHEN ; Z WANG ; J N SHI ; T ZHANG
Chinese Journal of Pathology 2023;52(9):949-951
8.The influence between managements in emergency room and outcome of severe traumatic brain injury
Jiangning XIE ; Zhengxing XIE ; Huizhong XU ; Huazhong CAI ; Zhiying CHANG ; Dequn DING ; Qixiang YIN ; Yapeng LIANG ; Cunzu WANG ; Dongyun CHEN ; Duqian WANG ; Yongzhong FAN
Chinese Journal of Postgraduates of Medicine 2013;(2):6-8
Objective To assess the influence between managements in emergency room(ER) andoutcome of severe traumatic brain injury (TBI),in order to provide inference for treatment.Methods A retrospective analysis was performed in severe TBI patients and recorded next indexes.(1) The managements in ER,including endotracheal intubation and oxygenation,fluid resuscitation,and mannitol intake.(2) The vital signs arriving at ICU,including systolic pressure and blood oxygen saturation.(3) Prognostic indicators including inhospital mortality and days during ICU,the scores of Glasgow outcome scale (GOS) at discharge and 6 months after injury.Results In 140 severe TBI patients,65 patients (46.4%) died during ICU.The mortality of patients with endotracheal intubation [65.0% (39/60)] was significantly higher than that without endotracheal intubation [32.5%(26/80)](P< 0.01).The mortality in whether fluid resuscitation and using mannitol had no significant difference [44.7% (46/103) vs.51.4% (19/37),49.2% (31/63) vs.44.2% (34/77)] (P >0.05).In days during ICU,there was no significant difference among the three treatment measures (P> 0.05).In GOS grade at discharge and 6 months after injury,the proportion of 4 and 5 grade were 8.3% (5/60) and 25.0% (15/60) in patients with endotracheal intubation,while 27.5% (22/80) and 52.5% (42/80) in patients without endotraeheal intubation (P < 0.01).In fluid resuscitation and using mannitol patients,there were no significant difference(P > 0.05).Conclusion Treating severe TBI patients in ER,endotracheal intubation should be carefully chosen,fluid resuscitation and mannitol may not be given.
9.Clinical Characteristics and Prognosis of Patients with Hematological Malignancies Superimposed with Solid Tumors.
Lin GUI ; Wei ZHANG ; Jing Ning SHI ; Wen Jing ZHANG ; Zhi Nan YANG ; Yong Chao MA ; Bao An CHEN
Journal of Experimental Hematology 2022;30(3):924-929
OBJECTIVE:
To investigate the clinical characteristics and prognosis of hematological malignancies superimposed patients with solid tumors.
METHODS:
The clinical data of 30 patients with more than two kinds of malignancy (the second is hematological malignancy) from October 2011 to October 2020 in Department of Hematology, Jiangning Hospital Affiliated to Nanjing Medical University were collected and analyzed retrospectively. The overall survival time was used as the prognostic evaluation standard, and the survival of patients were analyzed by KaplanMeier method. Logrank test and Cox regression model were used to carry out univariate and multivariate retrospective analysis on clinical and laboratory parameters of 30 patients.
RESULTS:
Among 30 cases, 20 were male, 10 were female, the median age of onset of the second tumor was 70 years old. The common types of the secondary hematological malignancies to solid tumors are myelodysplastic syndrome, acute myeloid leukemia, multiple myeloma. Univariate analysis showed that patients' gender, age, type of solid tumors, the onset of interval between two kinds of tumor, chromosome karyotype were not related to do with the patients' overall survival time. Type of hematologic disease, ECOG score were associated with patients' overall survival time, and the multivariate analysis showed that the type of hematologic disease and ECOG score were independent risk factors for patients with poor prognosis.
CONCLUSION
Patients superimposed with solid tumors complicated with myelodysplastic syndrome or acute leukemia and ECOG score ≥3 have poor prognosis and shorter overall survival time, which are independent risk factors influencing the prognosis. Bone marrow injury, immune dysfunction and genetic susceptibility after chemoradiotherapy may be the main causes of these diseases.
Aged
;
Female
;
Hematologic Neoplasms/complications*
;
Humans
;
Leukemia, Myeloid, Acute/complications*
;
Male
;
Myelodysplastic Syndromes/complications*
;
Prognosis
;
Retrospective Studies
10.Analysis of prognosis of acute myeloid leukemia patients based on genetic mutations.
Jinning SHI ; Yu ZHU ; Ming HONG ; Huihui ZHAO ; Jianping MAO ; Hui JIN ; Wenjing ZHANG ; Ting ZHANG ; Yongchao MA ; Yaoyu CHEN ; Sixuan QIAN ; Jianyong LI ; Chun QIAO
Chinese Journal of Medical Genetics 2017;34(6):806-811
OBJECTIVETo correlate the clinical features of patients with acute myeloid leukemia (AML) with mutations of FLT3-ITD, NPM1, CEBPA, c-KIT, DNMT3A and ND4 genes as well as chromosomal aberrations.
METHODSSomatic mutations of aforementioned genes in 412 newly diagnosed AML patients were detected with PCR and direct sequencing. All patients were also subjected to R-banding chromosomal analysis. The results were correlated with the clinical features and prognosis of the patients.
RESULTSThe mutation rates of FLT3-ITD, NPM1, CEBPA, c-KIT, DNMT3A and ND4 were 9.0% (26/289), 19.1% (50/262), 18.9% (34/180), 3.4% (7/208), 6.6% (9/137) and 6.9% (4/58), respectively. Patients with poor prognosis based on genetic mutations had lower blood platelet count than those with intermediate and good prognosis (P=0.001 and P=0.001, respectively). None of the three groups attained median overall survival (OS) (P> 0.05). The complete remission (CR) was similar among the three groups (P> 0.05). For patients with different prognosis based on cytogenetic findings, white blood cell count in those with intermediate prognosis was higher than those with good and poor prognosis (P< 0.001 and P=0.004, respectively), while the blood platelet count of the intermediate group was higher than that of the group with good prognosis (P=0.018). No significant difference was found among the three groups in terms of hemoglobin level (P> 0.05). The group with poor prognosis has attained shorter OS compared with those with good and intermediate prognosis (P< 0.001 and P=0.003, respectively). However, the CR rate of the group with good prognosis was higher than that of the intermediate group (P=0.001). For the group with intermediate prognosis, presence of genetic mutations did not correlate with the clinic characteristics such as white blood cell count, blood platelet count, hemoglobin level, OS and CR rate (P> 0.05 for all comparisons).
CONCLUSIONGenetic mutations combined with cytogenetic analysis can facilitate the prognosis and personalized treatment for patients with AML.
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Child ; Child, Preschool ; Female ; Humans ; Infant ; Leukemia, Myeloid, Acute ; genetics ; mortality ; Male ; Middle Aged ; Mutation ; Prognosis ; Young Adult